Novartis Pharmaceuticals Corp. will face trial on a cardiovascular sales specialist’s claim that she was paid less than a male colleague despite performing substantially equal work.

ProPublica and Hearst Newspapers together have defeated a defamation claim in Texas over a story questioning the ethics of a renowned heart transplant surgeon.

An increase in demand for cancer therapies drove better-than-expected results for Merck & Co. and AstraZeneca Plc, as a move toward early screening and rapid diagnosis led to more patients getting treatment.

GlaxoSmithKline filed a federal lawsuit seeking to recoup a share of the tens of billions of dollars in revenue Pfizer and BioNTech have reported from sales of their Covid-19 vaccines, which GSK alleges infringe five patents related to mRNA vaccine technology.

Pennsylvania-based Tower Health defeated a proposed class action alleging it shared patients’ personal health information with Meta Platforms Inc. in violation of the Electronic Communications Privacy Act and common law.

A federal judge overseeing litigation over allegedly inadequate side effect warnings on Ozempic and similar drugs appointed eight firms to leadership roles on the plaintiffs’ committee.